overig EMA committee recommends revocation of marketing authorisation for Novartis’ sickle cell disease medicine, Adakveo 29 mei 2023Pharma Biz
marketing Meer bereik met je LinkedIn-berichten: tips & tricks [infographic] 28 mei 2023Frankwatching.nl
onderzoek Keytruda plus Lenvima demonstrates long-term, durable survival benefit versus sunitinib as first-line treatment for patients with advanced RCC 28 mei 2023Pharma Biz
